Prosecution Insights
Last updated: November 04, 2026
Application No. 19/645,830

FORCE REDISTRIBUTION HINDFOOT SHOE INSERT

Non-Final OA §112§DP
Filed
Apr 13, 2026
Priority
Aug 10, 2021 — provisional 63/231,666 +2 more
Examiner
HAWTHORNE, OPHELIA ALTHEA
Art Unit
3786
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Roxilla LLC
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
2y 4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
947 granted / 1315 resolved
+2.0% vs TC avg
Strong +30% interview lift
Without
With
+30.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
41 currently pending
Career history
1358
Total Applications
across all art units

Statute-Specific Performance

§101
5.8%
-34.2% vs TC avg
§103
39.6%
-0.4% vs TC avg
§102
22.7%
-17.3% vs TC avg
§112
23.7%
-16.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1315 resolved cases

Office Action

§112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 2 is objected to because of the following informalities: the limitation, “it” should be replaced with the structure to which Applicant is seeking patent protection. Appropriate correction is required. Claim13 is objected to because of the following informalities: the term “heal” in line 2 of claim 13 should have read heel. Appropriate correction is required. Claim 13 is objected to because of the following informalities: the limitation, “..the a thickness..” in line 5 of the claim should read “..a [[the]] thickness..”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the top surface" in line 11 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 2 recites the limitation "the proximal-distal direction" in line 3 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 3 recites the limitation "the range" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 4 recites the limitation "the range" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 5 recites the limitation "the range" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 6 recites the limitation "the thickness direction" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the proximal-distal direction" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 8 recites the limitation "medial-lateral direction" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 10 recites the limitation "medial-lateral direction and proximal-distal direction" in lines 2-3 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 10 recites the limitation "the range" in line 3 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 11 recites the limitation "the top surface" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 12 recites the limitation "the top surface" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 12 recites the limitation "the range" in line 3 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 13 recites the limitation "the top surface" in line 3 and 5-6 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 15 recites the limitation "the top surface” in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 16 recites the limitation "the bottom surface" in lines 1-2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 17 recites the limitation "the top surface and the bottom surface" in line 2 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 19 recites the limitation "the top surface" in line 11 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claim 20 recites the limitation "the top surface" in line 11 of the claim. There is insufficient antecedent basis for this limitation in the claim. Claims 9,14 and 18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter since they depend directly or indirectly on rejected base claim 1 and therefore, contain the same deficiencies. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-10, 12-15 and 18-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-14, 16, 19 and 21 of U.S. Patent No. U.S. Patent No. (12,599,494 B2). Although the claims at issue are not identical, they are not patentably distinct from each other because the application claims are a broader recitation of the invention than that of the patented application. Claim 1 of the instant invention recites: a shoe insert device, comprising: a hindfoot insert portion comprising a proximal end, a distal end, a medial side extending between the proximal and distal ends, a lateral side extending between the proximal and distal ends, a top side and a bottom side, wherein the hindfoot insert portion is configured to be positioned within a shoe and extend beneath a hindfoot portion of a sole of a foot of a user within the shoe with the top side of the hindfoot insert portion facing the sole, wherein the hindfoot insert portion is resilient at least in a thickness direction extending between the top and bottom sides, wherein the hindfoot insert portion comprises: a fascia projection extending upwardly from the top surface positioned medially between the medial and lateral sides and being spaced distally from the proximal end; and a lateral projection positioned proximate to the lateral side and distal to the fascia projection that extends upwardly toward the sole of the foot of the user. Claim 1 of U.S. Patent No. U.S. Patent No. (12,599,494 B2) recites: a shoe insert device, comprising: a hindfoot insert portion comprising a proximal end, a distal end, a medial side extending between the proximal and distal ends, a lateral side extending between the proximal and distal ends, a top side and a bottom side, wherein the hindfoot insert portion is configured to be positioned within a shoe and extend beneath a hindfoot portion of a sole of a foot of a user within the shoe with the top side of the hindfoot insert portion facing the sole, wherein the hindfoot insert portion is resilient at least in a thickness direction extending between the top and bottom sides, wherein the hindfoot insert portion comprises: a fascia projection extending upwardly from the top surface positioned medially between the medial and lateral sides and being spaced distally from the proximal end; and a lateral projection extending upwardly from the top surface positioned proximate to the lateral side and distal to the fascia projection. Although the conflicting claims are not identical, they are not patentably distinct from each other because the difference between claim 1 of the current application and claim 1 of U.S. Patent No. (12,599,494 B2) lies in the fact that the patented claims include many more elements and is thus much more specific. Thus, the invention of claim 1 of U.S. Patent No. (12,599,494 B2) is in effect a “species” of the “generic” invention of current application claim 1. It has been held that the generic invention is “anticipated” by the “species". See In re Goodman, 29 USPQ2d 2010 (Fed. Cir. 1993). Since claim 1 of the current application is anticipated by claim 1 of U.S. Patent No. (12,599,494 B2) it is not patentably distinct from claim 1 of patent (12,599,494 B2). All of the limitations of claim 2 can be found in claim 2 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 3 can be found in claim 3 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 4 can be found in claim 6 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 5 can be found in claim 7 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 6 can be found in claim 8 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 7 can be found in claim 9 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 8 can be found in claim 10 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 9 can be found in claim 11 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 10 can be found in claim 12 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 12 can be found in claim 13 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 13 can be found in claim 4 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 14 can be found in claim 4 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 15 can be found in claim 14 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 18 can be found in claim 16 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 19 can be found in claim 19 of U.S. Patent No. (12,599,494 B2). All of the limitations of claim 20 can be found in claim 21 of U.S. Patent No. (12,599,494 B2). Allowable Subject Matter Claims 11, 16-17 are objected to as being dependent upon a rejected base claim, but would be allowable if a timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on a nonstatutory double patenting ground provided the conflicting application or patent either is shown to be commonly owned with this application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to OPHELIA ALTHEA HAWTHORNE whose telephone number is (571)270-3860. The examiner can normally be reached M-F 8:00 AM-5:00 PM, EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alireza Nia can be reached at 5712703076. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /OPHELIA A HAWTHORNE/Primary Examiner, Art Unit 3786
Read full office action

Prosecution Timeline

Apr 13, 2026
Application Filed
Oct 01, 2026
Non-Final Rejection mailed — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778793
VAGINAL PESSARY
2y 4m to grant Granted Nov 03, 2026
Patent 12779141
SYSTEM, APPARATUS, AND METHOD FOR PROVIDING PERIPHERAL INTRAVENOUS ACCESS
2y 2m to grant Granted Nov 03, 2026
Patent 12778812
Cut-Resistant Compression Sleeve
1y 12m to grant Granted Nov 03, 2026
Patent 12778794
IUD INSERTION DEVICES WITH STRING CONTROL
1y 9m to grant Granted Nov 03, 2026
Patent 12773343
OPTIONAL SHAPED RECTOCELE PADDLES
2y 8m to grant Granted Oct 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
99%
With Interview (+30.2%)
2y 11m (~2y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1315 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month